- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03944720
Efficacy of Transvaginal Repair for Rectocele
Prospective Evaluation on the Efficacy of Transvaginal Repair for Rectocel
Patients with rectoceles may present a variety of symptoms such as pelvic pressure, obstructive defecation or discomfort during sexual intercourse. The main symptom of the patient probably ends up conditioning if the patient is referred to a gynaecologist or a colorectal surgeon.
Different surgical techniques have been described to repair the rectocele. The posterior colporrhaphy is the preferred approach for most gynaecologists, while the transanal repair is the most common approach for the majority of colorectal surgeons. However, the small number of prospective studies, the inconsistent inclusion criteria and the variability of the outcome measures make difficult to know what the ideal surgical approach for a rectocele repair would be. Gynaecologists usually do not assess defecatory function before a rectocele repair, and studies focused on obstructive defecation include patients with other co-existing pathologies (rectal prolapse, rectal intussusception, enterocele) that may influence the success of the repair. Moreover, functional disorders such as the paradoxical contraction of the external anal sphincter or the puborectalis muscle are not systematically reported. On the other hand, many surgeons have questioned the transvaginal approach because it has been reported that patients may present dyspareunia after the surgery, although it is not systematically evaluated.
The hypothesis of the investigators is that the transvaginal approach for rectocele repair is an effective treatment for symptoms of obstructive defecation and is not associated with sexual dysfunction when the plication of the puborectalis muscle is not performed.
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Yolanda Ribas, MD PhD
- Phone Number: +347839388
- Email: yribas@cst.cat
Study Locations
-
-
Barcelona
-
Terrassa, Barcelona, Spain, 08227
- Consorci Sanitari de Terrassa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women
- Older than 18 year old
Symptoms of obstructed defecation associated to a rectocele with an indication for surgery according to the following criteria:
- Symptoms of obstructed defecation according to Rome III criteria: straining, sensation of incomplete evacuation, sensation of anorectal obstruction/blockage, and/or manual manoeuvres to facilitate defecation at least in 25% of defecations for the last 3 months
- Incomplete emptying of the rectocele on a defecography
- Failure of conservative treatment including dietary advice and laxatives, with persisting symptoms of obstructive defecation
- Recto-rectal intussusception may coexist on defecography (grade I and II of Oxford Prolapse Grading System)
- Non-obstructive enterocele may coexist on defecography (type A enterocele: the small bowel descends to puboccoccygeal line (PCL) during straining and returns to PCL at the end of the straining attempt without compressing the rectal ampulla or compressing it from above with no obstruction)
- Absence of anal sphincter dyssynergia on anorectal manometry, or successful rehabilitation after biofeedback in the case of previous dyssynergia
- Ability to understand the surgical procedure and the questionnaires of the study
- Written informed consent
Exclusion Criteria:
- Anal sphincter dyssynergia
- Coexisting recto-anal intussusception on defecography or external rectal prolapse (grades III, IV and V Oxford Prolapse Grading System)
- Coexisting enterocele compressing/obstructing the rectum on defecography (type B enterocele: the enterocele descends beyond the PCL to the perineum through the rectovaginal space to compress the rectal ampulla at the end of the evacuation process; type C enterocele (obstructive): the enterocele descends beyond the PCL to the perineum through the rectovaginal space to compress the rectal ampulla at the beginning of the evacuation process)
- Slow transit constipation associated to obstructed defecation
- Severe psychiatric disorder
- Refusal to provide written informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in symptoms of obstructive defecation measured by the Altomare obstructed defecation syndrome (ODS) score
Time Frame: Baseline, 6 months and 12 months after surgery
|
Assessment of the efficacy of the transvaginal approach for rectocele repair to improve symptoms of obstructive defecation according to the Altomare ODS score.
The Altomare ODS score is a validated questionnaire to assess the severity of the obstructed defecation syndrome, consisting of eight 3- o 4-point Likert-scaled symptom items.
Each of the items has four or five possible answers with scores ranging from zero (symptom free) to three or four points (more severe symptom).
The ODS score is the sum of all points, with a maximum possible of 31 points.
|
Baseline, 6 months and 12 months after surgery
|
Change in symptoms of obstructive defecation measured by the KESS score
Time Frame: Baseline, 6 months and 12 months after surgery
|
Assessment of the efficacy of the transvaginal approach for rectocele repair to improve symptoms of obstructive defecation according to the KESS score.
The KESS (Knowles-Eccersley-Scott-Symptom) score is a validated questionnaire to assist in diagnosing constipation and in discriminating among pathophysiologic subgroups, consisting of eleven questions.
Each question has four to five possible answers which are scored on an unweighted linear integer scale to produce a range between zero and three, or zero and four points.
Lower scores represent symptom-free states and higher scores, increased symptom severity.
The KESS score is the sum of all points, with a maximum possible of 39 points.
|
Baseline, 6 months and 12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in sexual function
Time Frame: Baseline, 6 months and 12 months after surgery
|
To assess changes in the Female Sexual Function Index (FSFI) questionnaire.
The FSFI score is a validated 19-item questionnaire to measure the sexual functioning in women, including six domains: desire, subjective arousal, lubrication, orgasm, satisfaction and pain.
Domain scoring is as follows: desire 2-10, arousal 0-20, lubrication 0-20, orgasm 0-15, satisfaction 2-15, pain 0-15.
Lower scores represent worse sexual functioning.
|
Baseline, 6 months and 12 months after surgery
|
Assessment of morbidity related to the surgical technique
Time Frame: Baseline, 6 months and 12 months after surgery
|
Description of the morbidity that may be related to any surgical technique
|
Baseline, 6 months and 12 months after surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 02-18-102-024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
-
Surgify Medical OyCompletedSurgery | Spine SurgeryFinland
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States